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Abstract 
Objective:  Permanent atrial fibrillation (pAF) is a serious problem in cardiac surgery: An 
incidence of 3.5% among all patients scheduled for open heart surgery, 9.8% in heart valve cases 
and 45.6% among patients with severe rheumatic mitral valve (MV) disease was observed in our 
institution. Our experience with radiofrequency (RF) ablation procedures to treat pAF in these 
cases   is   reported.                                                      
Methods:  Since February 2001 monopolar endocardial RF ablation procedures creating two 
encircling isolation lesions around the left and the right pulmonary veins (LPVs, RPVs) and a 
connection line between both were performed in patients with pAF concomitant to heart valve 
surgery. Since March 2003 bipolar RF ablation was used as an adjunct to CABG surgery. 
Amiodarone was given for 3 months after surgery.                                                                 
Results: Sixtytwo patients with pAF underwent surgical ablation procedures and primary valve 
(mitral: n=45; aortic: n=13; aortic+mitral: n=1; LA-diameter 55.6±7.3 mm) or CABG surgery 
(n=3). Follow-up was performed at 3, 6, 9, 12, 18 and 24 months; 75% had stable sinus rhythm 
(SR) at late follow-up. Almost 90% of the patients with a preoperative LA-diameter of <56mm 
had   SR.                                                                                  
Conclusion: Isolation of the PVs using RF ablation procedures in combination with amiodarone 
therapy represents a safe and efficient option to cure pAF in patients undergoing open heart 
surgery.
Keywords:  Atrial fibrillation; atrial fibrillation surgery; radiofrequency ablation; arrhythmia 
surgery; heart valve surgery; maze surgery; bipolar radiofrequency ablation.                              
Introduction
            In cardiac surgery strategies to treat permanent atrial fibrillation (pAF) effectively are of 
greatest   interest   because   pAF   is   a   frequent   problem   that   substantially   deteriorates   the 
prognosis1,2,3. The data concerning the incidence of pAF following the classification of the 
ACC/AHA/ESC Practice Guidelines4 that had been documented to persist for a period of at least 
6 months among all patients scheduled for open heart surgery in our institution between 
February 2001 and April 2003 are outlined in Table 1.
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            Since Cox has demonstrated that AF can be definitely eradicated5, efforts were made to 
achieve alternative and particularly less complex methods using surgical catheter ablation 
techniques during cardiac surgery. A broad spectrum of these methods has been presented 
recently6,7,8,9,10,11,12,13,14. Our experience with radiofrequency (RF) ablation procedures to treat 
pAF during open heart surgery is reported.
Material and methods
            Etiology of heart valve disease was assessed by clinical history, intraoperative valve 
examination and histological analysis. Patients hospitalized for heart valve surgery with pAF 
(>6months) underwent combined intraoperative AF treatment with monopolar RF ablation. 
Since March 2003 a bipolar RF ablation procedure was performed in CABG cases with pAF. 
Patients with any other form of AF (intermittent or pAF <6months), emergency operation, severe 
reduced left ventricular function (EF<25%), acute bacterial endocarditis, cachexia [Body Mass 
Index (BMI) <24], severe intracavitary thrombosis or extreme left atrial size were excluded (LA 
diameters of >72mm were assessed to be our limit for the procedure).
Surgical   procedure                                                                
Heart   valve   cases                                                                              
            The surgical procedure has been described detailed elsewhere15. To create endocardial 
RF ablation lesions two almost identical systems were used: either the Thermaline® device or 
(since 01/02) the Cobra® device (both Boston Scientific Corporation, San Jose, USA). 
Monopolar RF ablation was performed using 100W RF power for 120 sec, the local temperature 
was set at 70°C. The first lesion line completed the isolation of the right pulmonary veins 
(RPVs) from the inferior to the superior RPV using the left atriotomy. Isolation of the left 
pulmonary veins (LPVs) was performed with a semicircular ablation line close to the inferior, 
and another one around the superior LPV. These were connected by a transverse lesion across 
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the posterior wall of the LA (Fig.1 A). Arrangements to avoid thermic esophageal injury were: 
(1) cachectic patients were excluded, (2) a dry compress was passed behind the LA before 
delivery of RF energy, (3) the transesophageal echocardiogram (TEE) probe was removed 
during the ablation procedure, (4) a flexible ablation probe was used and adapted to the tissue 
without pressure, (5) local temperature was set at 70°C and (6) monopolar RF ablation was 
performed precisely under direct view during conventional open heart valve surgery only.
CABG   cases                                                                                
            The bipolar AtriCure device (AtriCure Inc., Cincinnati, USA) was used for an almost 
identical lesion pattern (Fig.1 B). The device consists of a hand piece, a footswitch, connecting 
cables and an ablation and sensing unit (ASU) that (1) delivers RF energy while simultaneously 
measuring the tissue conductance and (2) uses a temperature sensing mechanism (range of 45 - 
55°C). During ablation the tissue is impacted between two jaws of the hand piece and energy is 
delivered by footswitch. The ablation was finished when the ASU monitor indicated that the 
tissue conductance was at least 3 sec below 2.5 Millisiemens. After start of cardiopulmonary 
bypass isolation of the RPVs and the LPVs was performed by grasping the adjacent atrial tissue. 
Then a purse-string suture with a tourniquet was set at the posterior wall of the LA. The distal 
jaw was inserted through a small incision in direction of the LPVs and RF ablation was 
performed after clamp-closure, then the distal jaw was inserted in direction of the RPVs and the 
connection line was completed (Fig. 1B).
 
Fig. 1 Ablation schemes. LAA, left atrial appendage; LPVs, left pulmonary veins; RPVs, right 
pulmonary veins; MV, mitral valve.
Perioperative management, follow-up and statistical analysis                                                   
            The perioperative management has been described detailed elsewhere15. Standard 12-
lead   electrocardiogram   (ECG)   and   transthoracic   echocardiogram   (TTE)   were   routinely 
performed on admission (evaluation of LA diameter) and before discharge. Administration of 
amiodarone was started before end of cardiopulmonary bypass and given for 3 months after 
surgery. Early recurrence of AF was DC cardioverted after saturation with amiodarone. Patients 
with CABG, mitral valve (MV) repair or bioprosthesis got cumarine for 3 months, patients with 
mechanical valves lifelong anticoagulation. All patients were restudied 3, 6, 9, 12, 18 and 24 
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months   after   surgery   by   standard   12-lead   ECG   and   clinical   examination.   Quantitative 
preoperative and operative data were normally distributed and described by arithmetic mean ± 
standard deviation; qualitative distributed data were presented as absolute frequencies. For pAF 
and sinus rhythm (SR) the relative frequency among all patients and some subgroups were 
calculated. Qualitative characteristics were compared using the exact Fisher Chi-Square-Test. 
All   p-values   were  two-tailed  and  interpreted  nominal   that  is   not   adjusted  for   multiple 
comparisons. P-values <0.05 were considered to be statistically significant. Analysis was 
performed with SPSS for Windows 11.5.1.
Results
Heart valve cases                                                                                                       
            Fifty-nine patients underwent surgical pAF ablation procedures associated with primary 
valve operations (Table 2). From these patients 45 had MV, 13 AV and 1 AV+MV surgery; 13 
were excluded. The main group suffered from rheumatic heart valve disease (39/59). Mean LA 
diameter was 55.6±7.1mm, 32 patients had a small (<56mm) and 27 patients a large LA 
(>56mm).There were two cases of hospital mortality (3.4%; 1 cardiac, 1 non-cardiac). Mean 
follow-up time up to April 2003 was 14.1 ± 9.9 months (Table 3). One-year-survival was 
91.7%; late mortality was related to cancer disease (n=2) and sudden death (n=1). At late follow-
up approximately 75% of all patients and almost 90% of those with a preoperative LA-diameter 
of <56mm were in stable SR. Early postoperative recurrence of AF during the first 3 months 
(32/59) was DC cardioverted in 13 of 25 cases, 6 turned to SR spontaneously later. Preoperative 
duration of AF was not predictive for long term results.                                         
CABG   cases                                                                                          
            In 3 bipolar RF ablation cases (Table 2) no severe complication occurred. At end of 
surgery 2 patients were externally paced in DDD-mode, one was in SR. Early postoperative 
return of AF was DC cardioverted in 1 of 2 cases; 2 of 3 patients left the hospital in SR.
Discussion
Rationale of surgical practices to treat pAF                                                                         
            Reliable and effective treatment strategies for pAF are of greatest interest in cardiac 
surgery because pAF causes two times higher rates of death, five times higher risk of stroke, 
reduced cardiac output and the need of systemic anticoagulation with the danger of bleeding1-3. 
The incidence among patients scheduled for open heart surgery is particularly high among heart 
valve cases and of special importance in MV disease15. That is why most of the recently reported 
surgical AF ablation data were observed following heart valve (particularly MV) surgery6,-14. 
The permanent form of AF is one of two AF-types (permanent and intermittent) and normally 
the final mode in which non-permanent AF cumulates4: patients with pAF have atrial fibrillation 
all of the time without any episode of SR. The variant clinical presentations of permanent and 
intermittent AF have unfortunately caused heterogeneous nomenclatures in different countries 
with currently used misleading terms (chronic, paroxysmal or persistent AF) and the resulting 
difficulty   to   compare   the   success-rates   of   different   groups.  
             During the past years mainly three different energy sources have been favoured for 
surgical practice to create atrial lesions to cure these AF-types; RF energy has been established 
for variant treatment strategies and became the most widely used energy source for AF surgery8-
12. The use of microwave13,14  and cryoablation6  has been described alternatively. In these 
investigations8-12 RF energy was used without exception in monopolar fashion for endocardial 
or/and epicardial ablation techniques with more or less comparable and successful results. 
However, two theoretical deficiencies remain with the application of monopolar RF energy: (1) 
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transmurality  of   the  created  lesions   is  not  definitely  guaranteed  and  (2)   rare   but  fatal 
complications because of too deep lesions have occurred16,17. Experiences with possibly reliable 
bipolar RF ablation techniques that guarantee lesion transmurality and continuity and definitely 
bar extra-cardiac tissue injury are therefore of great interest.
Table 2: Preoperative and operative data (n=62) 
 
*including adjustment of the equipment and a precise adaption of the probe to the 
tissue   (Thermaline   /   Cobra)   and   preparation   of   the   PVs   (Atricure);   deg, 
degenerative MV disease; bio, bioprosthesis; mech, mechanical valve.
            Many surgeons who used ablation techniques in the past followed more or less closely 
the principles of the Maze procedure which are PV isolation, reduction of atrial size and block of 
re-entrant circuits by complex incisions8,9,11,12. An ideal lesion pattern should combine (1) slight 
invasiveness, (2) simplicity, (3) high reproducibility and (4) saving of time with excellent 
success rates in almost all cases. The question if such a lesion pattern is actually applied in 
practice must be answered negative. The mechanisms of AF initiation and maintenance 
obviously vary and are connected with individual electrophysiological and pathological atrial 
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tissue changes in cases with AF and particularly pAF18-20. It is possible that individual patients 
with pAF probably need individual surgical ablation procedures. The relevant questions are: (1) 
does a lesion pattern exist which can be recommended as a basis and can be completed easily 
according to the individual pathological or electrophysiological substrate and (2) can patients be 
defined who need specific additional ablation procedures?                                               
            Referring to this Haissaguerre has described an important pathophysiologic finding: he 
demonstrated that the initiation of AF originates from rapidly firing foci predominantly located 
inside the PVs21. According to that the concept was developed that isolation of the PVs creating 
transmural encircling RF ablation lesions around the LPVs and the RPVs should be a sufficient 
basis for surgical ablation procedures. To save LA function and to bar potential generation of 
foci the maze pattern of multiple incisions was reduced to a short connection line between both. 
During valve surgery RF ablation was performed from the endocardial side with direct view on 
the atrial tissue to guarantee continuity of the lesions. A new bipolar RF approach was recently 
used in primary CABG cases with pAF as an endocardial proceeding would have been of 
obvious disadvantage because of greater invasiveness and prolonged aortic cross clamping time 
in these cases. Amiodarone was normally given to reduce postoperative recurrence of AF22. 
 
Evaluation of the results                                                                                             
             Our results conform to basic experiences of other research  5,21,23,24: AF wavelets 
sustained by foci located inside the PVs were blocked by the created lesions, the described 
antiarrhythmic   protection   supported   SR22  during   the   unstable   initial   stage,   which   was 
approximately 3 months. Early recurrence of AF after ablation surgery obviously occurred due to 
the fact that the refractory period of the atrium was still shortened. In the case of AF recurrence 
DC cardioversion was still recommended, so the influence on the long-term results must be 
further clarified. Our data indicate that the preoperative LA size is of significant concern for the 
success of the described method. However, it remains uncertain whether the LA size itself is the 
critical issue. It can be expected that rather cellular, structural morphologic and in parallel 
electrophysiological changes of the atrial tissues are more marked in cases with progressive 
enlargement and hypertrophy of the atria18-20; this electrical and anatomic atrial remodeling is 
supposed to be the reason for what has been decscribed as AF begats AF25. It must be conceded 
that an additional effect may be that in cases with small LA the encircling lesions possibly 
encompassed larger portions of the LA in comparison to its overall size than in patients with 
large LA; in that cases re-entrant circuits in the LA tissue could be interrupted more frequently. 
Besides LA reduction has been described to be of advantage for restoring SR in patients with 
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chronic AF and large LA following MV surgery26.                                                   
            Even if our patients were approximately a decade older compared to patients of other 
studies9,10  surgery was tolerated well, particularly no case of esophageal injury16,17  was 
observed. Also confirmed was the increase of SR during the following months after surgery8-11. 
It can be suggested that a 3 months administration of amiodarone is appropriate but should be 
handled flexible. The described procedures are of slight invasiveness and easy to perform. The 
lesion pattern can be created with monopolar RF energy and with a bipolar approach as well. 
However, it will have to be shown, if the results with bipolar RF energy are as encouraging as 
the described data in valve patients. As for MV surgery the LA has to be opened anyhow we 
continue to recommend for the present an endocardial ablation technique for these patients.
Limitations
            For rhythm evaluation only 12-lead ECG was used. We consider to complete the follow-
up data by performing a 24-hour-ECG registry to assess the possibility of nonpermanent AF. The 
data were not evaluated under randomized conditions.
Conclusion
            We suppose that the described concept provides a successful treatment of pAF in patients 
undergoing open heart surgery; it fulfils all demands of an effective and easy to handle method. 
It simplifies the treatment of pAF and can be recommended in patients undergoing cardiac 
surgery. The advantages compared to other techniques are: (1) the procedure is easy to practice 
and (2) atrial tissue trauma is extremely slight. Our data indicate that particularly in patients with 
small LA restoration of stable SR in 90% of the cases can be achieved.                                  
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